United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market (2025-2031) | Segmentation, Trends, Value, Share, Analysis, Growth, Competitive Landscape, Companies, Industry, Forecast, Outlook, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market - Industry Life Cycle

3.4 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market - Porter's Five Forces

3.5 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market Revenues & Volume Share, By Dosage, 2021 & 2031F

3.6 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about the importance of vaccination in preventing pneumococcal diseases.

4.2.2 Government initiatives promoting vaccination programs.

4.2.3 Growing elderly population in the UK, who are at higher risk of pneumococcal infections.

4.3 Market Restraints

4.3.1 High cost associated with pneumococcal polysaccharide vaccines.

4.3.2 Limited accessibility to healthcare services in some regions of the UK.

4.3.3 Potential side effects or safety concerns associated with the vaccine.

6.1 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market, By Dosage

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Dosage, 2021- 2031F

6.1.3 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Single Dose Vial, 2021- 2031F

6.1.4 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Pre-Filled Syringe, 2021- 2031F

6.2 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market, By End User

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Children (2-10 Age), 2021- 2031F

6.2.3 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Adult (10-64 Age), 2021- 2031F

6.2.4 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market Revenues & Volume, By Geriatric (More Than 65 Age), 2021- 2031F

7.1 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market Export to Major Countries

7.2 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market Imports from Major Countries

8.1 Vaccination coverage rate among the elderly population.

8.2 Number of government-funded vaccination campaigns.

8.3 Rate of adverse reactions reported post-vaccination.

8.4 Research and development investment in new and improved pneumococcal vaccines.

8.5 Number of healthcare facilities offering pneumococcal vaccination services.

9.1 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market Opportunity Assessment, By Dosage, 2021 & 2031F

9.2 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Pneumococcal Polysaccharide Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters